US Executive Compensation Proxy SEC Filings — June 15, 2026

15-06-2026

Southern California Gas Co. filed a DEF 14A proxy statement for a special meeting to vote on an amendment to its Articles of Incorporation that would eliminate all classes of preferred stock and preference stock, leaving only common stock outstanding. As of the record date (June 12, 2026), there were 91,300,000 common shares, 79,011 Preferred Stock shares, and 783,032 Series A Preferred Stock shares outstanding. The amendment would have no effect on common stock or the interests of the sole common stockholder (PE), which will still receive the Retirement Payment on preferred stock it owns.

• · Preferred Stock is listed on OTC Markets under symbol 'SOCGM'.
• · Series A Preferred Stock is listed on OTC Markets under symbol 'SOCGP'.
• · Dividends on preferred stock are cumulative at 6% annual rate on $25 par value.
• · Holders of preferred stock, preference stock, and common stock each have one vote per share and vote together on all matters except those requiring a class vote.
• · Preferred stock has no conversion rights, sinking fund, or redemption provisions.
• · Internet and telephone voting closes at 11:59 p.m. Eastern Time on August 5, 2026.
• · Record date for the special meeting is June 12, 2026.

15-06-2026

Eagle Materials Inc. filed its definitive proxy statement (DEF 14A) on June 15, 2026, for the 2026 Annual Meeting of Stockholders to be held on July 30, 2026. The meeting will include the election of three Class II directors, an advisory vote on named executive officer compensation, and votes on amendments to declassify the Board and create a stockholder right to call special meetings, as well as ratification of Ernst & Young LLP as independent auditors for fiscal year ending March 31, 2027. The record date for voting is June 1, 2026.

• · The 2026 Annual Meeting will be held on Thursday, July 30, 2026, at 8:00 a.m. local time at the Douglas Conference Center, 8343 Douglas Avenue, Suite 125, Dallas, TX 75225.
• · The record date for stockholders entitled to vote is June 1, 2026.
• · The Board recommends voting FOR all five proposals: election of directors, advisory vote on executive compensation, declassification amendment, special meeting right amendment, and ratification of auditors.
• · Stockholders may vote via the Internet at www.proxyvote.com, by telephone, or by returning a proxy card.
• · The proxy materials were first mailed to stockholders on or about June 15, 2026.

15-06-2026

Jasper Therapeutics, Inc. filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Stockholders to be held virtually on July 31, 2026. The meeting will include the election of two Class II directors, ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year 2026, and an advisory vote on named executive officer compensation. The board recommends voting FOR all proposals.

• · The annual meeting will be held virtually via live audio webcast at https://www.cstproxy.com/JasperTherapeutics/2026.
• · Record date for voting is June 5, 2026.
• · Notice of Internet Availability of proxy materials will be mailed on or about June 18, 2026.
• · Proposal 1: Election of two Class II directors (Judith Shizuru and Tom Wiggans) to serve until 2029 annual meeting.
• · Proposal 2: Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.
• · Proposal 3: Advisory vote on compensation of named executive officers.
• · Board recommends FOR all proposals.
• · Stockholders may request paper copies by emailing proxy@continentalstock.com or calling 1-888-266-6791.

15-06-2026

Barings Global Short Duration High Yield Fund (BGH) filed a definitive proxy statement (DEF 14A) on June 15, 2026, for its virtual annual meeting of shareholders scheduled for August 4, 2026. The sole proposal is to elect Thomas W. Okel as Trustee for a three-year term. The Board of Trustees, including all independent trustees, unanimously recommends voting 'FOR' the proposal. As of the record date of June 5, 2026, there were 20,082,411 shares outstanding.

• · The annual meeting will be held virtually on August 4, 2026, at 4:00 p.m. Eastern Time at www.virtualshareholdermeeting.com/BGH2026.
• · Shareholders of record as of June 5, 2026 are entitled to vote; each share carries one vote with no cumulative voting rights.
• · A quorum requires 30% of shares entitled to vote.
• · The proxy materials are being mailed on or about June 15, 2026.
• · Shareholders can vote by proxy card, internet, or during the virtual meeting; broker non-votes count for quorum but not for the proposal.
• · If the proposal does not receive sufficient votes, the meeting may be adjourned for further solicitation.

15-06-2026

FlexShares Trust filed a definitive proxy statement (DEF 14A) on June 15, 2026, for a shareholder meeting on July 24, 2026, to elect eight trustees to the Board. The proposal aims to unify the boards of the FlexShares Funds and the NF/NIF Funds under a single board, with seven new independent trustee nominees and one current interested trustee nominee, Paula Kar. The Board unanimously recommends a vote FOR all nominees, citing governance efficiencies, expanded marketing opportunities, and a two-year expense reimbursement agreement from the adviser.

• · Shareholder meeting date: July 24, 2026 at 10:00 a.m. Central time at The Northern Trust Company, 50 South LaSalle Street, Chicago, IL 60603.
• · Record date for voting: June 12, 2026.
• · Proxy materials mailing date: on or about June 23, 2026.
• · Each share entitles the holder to one vote; no cumulative voting rights.
• · Shareholders holding through a broker must obtain a 'legal proxy' to vote in person.
• · Current FlexShares Trustees (except Ms. Kar) are expected to retire upon election of the new board.
• · The proposal is part of a succession plan for the FlexShares Board.
• · NTI agreed to extend the contractual expense reimbursement agreement for two years from the election and seating of the new board.
• · Proxy solicitor will be paid a project management fee plus expenses; total estimated at $400,000.
• · Shareholders can vote by telephone, internet, or mail; instructions on proxy card.
• · Trust contact number: 855-353-9383 (business hours 8:00 a.m. – 4:00 p.m. Central time, Mon–Fri).

15-06-2026

Cross Country Healthcare, Inc. has entered into a definitive merger agreement to be acquired by KL Criss Cross Intermediate, LLC (affiliated with Knox Lane LP) for $13.25 per share in cash, representing a 31% premium over the closing price on May 6, 2026, and a 45% premium over the 90-day VWAP. The transaction requires stockholder approval at a special meeting on July 16, 2026, and the board has unanimously recommended a vote 'FOR' the merger. However, stockholders who do not vote will effectively count as votes 'AGAINST' the proposal, and the merger cannot proceed without majority approval.

• · The special meeting will be held virtually on July 16, 2026 at 12:00 p.m. Eastern Time.
• · Record date for voting is June 12, 2026.
• · Stockholders who do not vote will have the same effect as a vote 'AGAINST' the merger agreement proposal.
• · The merger agreement was entered into on May 6, 2026.
• · The board of directors unanimously approved the merger and recommends voting 'FOR' all proposals.
• · Stockholders have appraisal rights under Delaware law if they do not vote in favor and comply with statutory procedures.
• · The merger consideration is $13.25 per share in cash, without interest, subject to withholding taxes.
• · The merger is subject to approval by holders of at least a majority of the outstanding voting power.

15-06-2026

VF Corp's fiscal 2026 proxy statement highlights a return to full-year revenue growth for the first time in three years, with revenue of $9.6B (up 1% ex-Dickies in constant dollars) and gross margin expansion of 130 bps to 54.8%. However, Vans® revenue declined 9% (down 11% in constant dollars), and APAC revenue was down 1%. The company reduced net debt from ~$5.8B to $2.7B and lowered leverage from 5.1x to 3.1x, aided by the sale of Dickies. The Board recommends voting FOR all management proposals, including director elections and executive compensation, and AGAINST a shareholder proposal on animal-derived materials.

• · The company recognized a non-cash impairment charge of $30.7M related to the Napapijri reporting unit goodwill.
• · Total cash shareholder returns of $141M through dividends in fiscal 2026.
• · VF expects to achieve an exit run rate of at least 10% adjusted operating margin by fiscal 2028 and a leverage ratio of 2.5x or lower by fiscal 2028.
• · The sale of Dickies closed in November 2025.
• · The Board's average tenure is 8.5 years, with two new directors added in the last two years.
• · Shareholders representing nearly 70% of outstanding shares were contacted for engagement; meetings were held with eight shareholders representing nearly 40% of outstanding shares.
• · All directors and executive officers are prohibited from hedging/pledging shares.
• · The shareholder proposal requests a report on an animal-derived materials policy; the Board recommends voting AGAINST.
• · The record date for the annual meeting is June 2, 2026.